Altoris Inc develops software for the Life Sciences, especially in the Biotechnology and Pharmaceutical industries. In a parallel effort, Altoris is using in-house these and other proprietary technologies for the development of new pharmacological agents. Their initial focus is on the development of oxidoreductase inhibitors as pharmacotherapies for cancer, metabolic disorders and cognitive impairment
